Validation of the Myelofibrosis Secondary to PV and ET-Prognostic Model in Newly Diagnosed Patients with Post-Polycythemia Vera and Post-Essential Thrombocythemia Myelofibrosis: MD Anderson Cancer Center

被引：0
|
作者：
Masarova, Lucia [1 ]
Kantarjian, Hagop [1 ]
Verstovsek, Srdan [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MPN-031
引用
收藏
页码：S20 / S21
页数：2
相关论文
共 50 条
  • [1] Validation of the Myelofibrosis Secondary to PV and ET-Prognostic Model in Patients with Post-Polycythemia Vera and Post-Essential Thrombocythemia Myelofibrosis: MD Anderson Cancer Center
    Masarova, Lucia
    Bose, Prithviraj
    Pemmaraju, Naveen
    Daver, Naval
    Cortes, Jorge E.
    Estrov, Zeev
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    BLOOD, 2017, 130
  • [2] Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis
    A Tefferi
    L Saeed
    C A Hanson
    R P Ketterling
    A Pardanani
    N Gangat
    Leukemia, 2017, 31 : 2851 - 2852
  • [3] Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis
    Tefferi, A.
    Saeed, L.
    Hanson, C. A.
    Ketterling, R. P.
    Pardanani, A.
    Gangat, N.
    LEUKEMIA, 2017, 31 (12) : 2851 - 2852
  • [4] The Evolving Understanding of Prognosis in Post-Essential Thrombocythemia Myelofibrosis and Post-Polycythemia Vera Myelofibrosis vs Primary Myelofibrosis
    Masarova, Lucia
    Verstovsek, Srdan
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (05) : 299 - 307
  • [5] Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis
    Masarova, Lucia
    Bose, Prithviraj
    Daver, Naval
    Pemmaraju, Naveen
    Newberry, Kate J.
    Manshouri, Taghi
    Cortes, Jorge
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    LEUKEMIA RESEARCH, 2017, 59 : 110 - 116
  • [6] Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement
    Sliwa, Thamer
    Beham-Schmid, Christine
    Burgstaller, Sonja
    Buxhofer-Ausch, Veronika
    Gastl, Guenther
    Geissler, Klaus
    Krauth, Maria
    Krippl, Peter
    Lang, Alois
    Petzer, Andreas
    Woehrer, Stefan
    Woelfler, Albert
    Gisslinger, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 (9-10) : 293 - 302
  • [7] Solid Tumors in Post-Polycythemia Vera and Post-Essential Thrombocythemia Myelofibrosis: A Study on 2220 Patients
    Mora, Barbara
    Rumi, Elisa
    Guglielmelli, Paola
    Barraco, Daniela
    Maffioli, Margherita
    Rambaldi, Alessandro
    Caramella, Marianna
    Komrokji, Rami S.
    Gotlib, Jason R.
    Kiladjian, Jean-Jacques
    Cervantes, Francisco
    Devos, Timothy
    Palandri, Francesca
    De Stefano, Valerio
    Ruggeri, Marco
    Silver, Richard T.
    Benevolo, Giulia
    Albano, Francesco
    Cavalloni, Chiara
    Pietra, Daniela
    Barbui, Tiziano
    Rotunno, Giada
    Cazzola, Mario
    Vannucchi, Alessandro M.
    Giorgino, Toni
    Passamonti, Francesco
    BLOOD, 2018, 132
  • [8] Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients
    Mora, Barbara
    Guglielmelli, Paola
    Kuykendall, Andrew
    Rumi, Elisa
    Maffioli, Margherita
    Palandri, Francesca
    De Stefano, Valerio
    Caramella, Marianna
    Salmoiraghi, Silvia
    Kiladjian, Jean-Jacques
    Gotlib, Jason
    Iurlo, Alessandra
    Cervantes, Francisco
    Ruggeri, Marco
    Silver, Richard T.
    Albano, Francesco
    Benevolo, Giulia
    Ross, David M.
    Della Porta, Matteo G.
    Devos, Timothy
    Rotunno, Giada
    Komrokji, Rami S.
    Casetti, Ilaria C.
    Merli, Michele
    Brociner, Marco
    Caramazza, Domenica
    Auteri, Giuseppe
    Barbui, Tiziano
    Cattaneo, Daniele
    Bertu, Lorenza
    Arcaini, Luca
    Vannucchi, Alessandro M.
    Passamonti, Francesco
    LEUKEMIA, 2022, 36 (10) : 2453 - 2460
  • [9] Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement
    Thamer Sliwa
    Christine Beham-Schmid
    Sonja Burgstaller
    Veronika Buxhofer-Ausch
    Günther Gastl
    Klaus Geissler
    Maria Krauth
    Peter Krippl
    Alois Lang
    Andreas Petzer
    Stefan Wöhrer
    Albert Wölfler
    Heinz Gisslinger
    Wiener klinische Wochenschrift, 2017, 129 : 293 - 302
  • [10] Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients
    Barbara Mora
    Paola Guglielmelli
    Andrew Kuykendall
    Elisa Rumi
    Margherita Maffioli
    Francesca Palandri
    Valerio De Stefano
    Marianna Caramella
    Silvia Salmoiraghi
    Jean-Jacques Kiladjian
    Jason Gotlib
    Alessandra Iurlo
    Francisco Cervantes
    Marco Ruggeri
    Richard T. Silver
    Francesco Albano
    Giulia Benevolo
    David M. Ross
    Matteo G. Della Porta
    Timothy Devos
    Giada Rotunno
    Rami S. Komrokji
    Ilaria C. Casetti
    Michele Merli
    Marco Brociner
    Domenica Caramazza
    Giuseppe Auteri
    Tiziano Barbui
    Daniele Cattaneo
    Lorenza Bertù
    Luca Arcaini
    Alessandro M. Vannucchi
    Francesco Passamonti
    Leukemia, 2022, 36 : 2453 - 2460
12345